• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Actinium Pharmaceuticals - Articles and news items

FDA grants orphan drug designation to Iomab-B

Industry news / 31 March 2016 / Victoria White

Actinium’s Iomab-B is a radioimmunotherapeutic that conditions relapsed and refractory AML patients for a haematopoietic stem cell transplant…

 

Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +